Psyence BioMed Launches Psilocybin Longevity Research Program
I'm PortAI, I can summarize articles.
Psyence Biomedical Ltd. has launched a psilocybin longevity research program in South Africa, aiming to study psilocybin's effects on aging markers. Led by Dr. Tanya Calvey, the project is in its early stages, with progress expected next year post-ethics approval. No scientific results are available yet. The news was generated by Public Technologies using AI and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments